If you have lymphoma, a type of white blood cell in your immune system has started growing out of control. These abnormal cells build up in your lymph nodes and other tissues, forming tumors that crowd out healthy cells and weaken your body’s ability to fight infections. Lymphoma can stay confined to one group of lymph nodes or spread to your bone marrow, spleen, liver, lungs, and even your brain or digestive tract. What happens next depends heavily on which type you have and how far it has spread.
How Lymphoma Affects Your Body
Your lymphatic system produces white blood cells called lymphocytes, and their job is to fight off infections. Lymphoma starts when DNA mutations cause one type of lymphocyte to multiply rapidly and live far longer than normal. These diseased cells accumulate in your lymph nodes (the small, bean-shaped glands in your neck, armpits, and groin) and eventually form masses of tissue that push out healthy cells.
As these tumors grow, your immune system becomes increasingly compromised. Your body produces fewer functional infection-fighting cells, which means you’re more vulnerable to bacterial and viral infections. If the cancer spreads to your bone marrow, it can interfere with the production of red blood cells and platelets too, leading to anemia and easy bruising or bleeding. An enlarged spleen is common, since the spleen is part of the lymphatic system and often becomes packed with cancerous cells.
Hodgkin vs. Non-Hodgkin Lymphoma
The two main categories are Hodgkin lymphoma and non-Hodgkin lymphoma, and the distinction comes down to what the cancer cells look like under a microscope. If a specific abnormal cell called a Reed-Sternberg cell is present, it’s classified as Hodgkin lymphoma. If that cell is absent, it’s non-Hodgkin.
Hodgkin lymphoma usually starts from B cells and tends to appear in predictable locations: the lymph nodes in your neck, chest, groin, or armpits. It typically spreads in an orderly pattern from one lymph node group to the next, which makes it easier to track and treat. Non-Hodgkin lymphoma can arise from B cells, T cells, or natural killer cells, and it’s more unpredictable. It can start in lymph nodes but is often found outside them as well.
Non-Hodgkin lymphoma is far more common and has dozens of subtypes. Some are aggressive and grow quickly, while others behave more like chronic conditions that relapse over many years. Hodgkin lymphoma is generally more curable, while non-Hodgkin lymphoma has a more variable outlook depending on the subtype.
Symptoms You Might Notice
The most common first sign is painless swelling in a lymph node, usually in the neck, armpit, or groin. You might feel a lump that doesn’t go away after a few weeks. Beyond that, lymphoma produces a well-known set of “B symptoms” that signal the disease is actively affecting your whole body:
- Unexplained fevers that come and go over days or weeks without any sign of infection
- Drenching night sweats severe enough to soak your sheets
- Unintentional weight loss of at least 10% of your body weight over six months
Other symptoms include persistent fatigue, itchy skin, and a feeling of fullness or pressure in your abdomen if your spleen is enlarged. If lymphoma grows in your chest, it can press on the large vein that carries blood back to your heart, causing swelling in your face, neck, and arms along with difficulty breathing.
How Lymphoma Is Diagnosed
Diagnosis usually starts with a physical exam checking for swollen lymph nodes and an enlarged spleen or liver. Blood tests can reveal abnormalities in your blood cell counts, but the definitive step is a biopsy. A surgeon removes all or part of a swollen lymph node so pathologists can examine the cells under a microscope and identify the specific type of lymphoma.
If lymphoma is confirmed, you’ll likely have imaging scans (PET, CT, or MRI) to see where the cancer has spread. A bone marrow biopsy, where a needle is used to collect a small sample of tissue and fluid from inside your hip bone, helps determine whether cancer has reached the marrow. In some cases, if lymphoma is suspected in the stomach or intestines, an endoscopy may be used to take tissue samples from the digestive tract.
Staging: How Far It Has Spread
Lymphoma is staged from I to IV using a system that maps how many areas of your body are involved:
- Stage I: Cancer is in a single lymph node region or a single organ outside the lymphatic system
- Stage II: Two or more lymph node regions are involved, but all are on the same side of the diaphragm (the muscle separating your chest from your abdomen)
- Stage III: Lymph nodes on both sides of the diaphragm are affected, and the spleen may be involved
- Stage IV: The cancer has spread widely to organs outside the lymphatic system, such as the liver, bone marrow, lungs, or cerebrospinal fluid
About a third of non-Hodgkin lymphoma cases are already at Stage IV by the time they’re diagnosed. That sounds alarming, but Stage IV lymphoma is not the same as Stage IV in many solid-tumor cancers. Lymphoma is a blood cancer that travels through a system designed to circulate throughout the body, so widespread involvement is expected and doesn’t necessarily mean the cancer is untreatable.
Treatment and What to Expect
Treatment depends on the type of lymphoma, its stage, and how aggressively it’s growing. For slow-growing (indolent) lymphomas that aren’t causing symptoms, your doctor may recommend a “watch and wait” approach with regular monitoring rather than immediate treatment. These types often can’t be fully cured but can be managed for many years.
For aggressive lymphomas, treatment typically starts with a combination of chemotherapy drugs and an antibody-based therapy that targets a protein on the surface of cancerous B cells. This combination is the standard first-line approach for most aggressive non-Hodgkin lymphomas. Treatment usually involves multiple cycles spread over several months. Side effects commonly include fatigue, nausea, hair loss, and increased infection risk due to lowered blood counts.
If lymphoma comes back after initial treatment or doesn’t respond to it, newer options exist. One of the most significant advances is CAR T-cell therapy, where your own immune cells are collected, genetically reprogrammed in a lab to recognize and attack lymphoma cells, and then infused back into your body. This approach is now a standard option for aggressive B-cell lymphomas that have relapsed after two or more rounds of prior treatment. Multiple CAR T-cell products are available, including options for specific subtypes like mantle cell lymphoma and follicular lymphoma.
Survival Rates by Stage
For non-Hodgkin lymphoma overall, the five-year relative survival rate is about 74%, based on data from 2015 to 2021. That number shifts significantly depending on how far the cancer has spread at diagnosis:
- Stage I (confined to one region): 87.7%
- Stage II (multiple regions, same side): 79.1%
- Stage III (both sides of diaphragm): 73.9%
- Stage IV (widespread): 63.8%
Hodgkin lymphoma generally has higher survival rates. These numbers represent averages across all subtypes and ages, so individual prognosis can vary widely. Younger patients and those with certain subtypes tend to do significantly better.
Living with Lymphoma During Treatment
Cancer-related fatigue is one of the most disruptive parts of having lymphoma. It goes beyond normal tiredness and can make even simple daily tasks feel overwhelming. One practical approach is energy conservation: tracking your energy levels with a diary or planner to identify your best hours, then scheduling important activities during those windows.
Gentle physical activity, even though it feels counterintuitive when you’re exhausted, can actually help reduce fatigue. Walking, light stretching, or yoga are common starting points. Staying hydrated and eating at least three meals a day also helps maintain energy, even when appetite is low from treatment side effects.
What Happens After Treatment Ends
Once lymphoma goes into remission, you’ll enter a surveillance period with regular follow-up appointments. The exact schedule depends on your type of lymphoma. For some types, follow-up CT scans are recommended every six months for the first two years, then annually. For others, scans are only done if new symptoms appear. Blood work monitoring for signs of relapse is part of routine follow-up, though no single blood test reliably catches a recurrence on its own.
If you received radiation therapy to your chest or neck, long-term monitoring for thyroid problems and heart-related risk factors becomes part of your ongoing care, since radiation to those areas can affect thyroid function and cardiovascular health years later. The frequency of follow-up gradually decreases over time if you remain in remission, but most people continue some level of monitoring for at least five years.